Janus Henderson Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Hold |
36,543
| – | – | ﹤0.01% | 1482 |
|
|
2025
Q1 | $1.38M | Hold |
36,543
| – | – | ﹤0.01% | 1459 |
|
|
2024
Q4 | $1.54M | Hold |
36,543
| – | – | ﹤0.01% | 1454 |
|
|
2024
Q3 | $2.03M | Sell |
36,543
-35,200
| -49% | -$1.95M | ﹤0.01% | 1306 |
|
|
2024
Q2 | $2.95M | Buy |
71,743
+39,592
| +123% | +$1.63M | ﹤0.01% | 1076 |
|
|
2024
Q1 | $1.5M | Buy |
32,151
+13
| +0% | +$607 | ﹤0.01% | 1423 |
|
|
2023
Q4 | $1.54M | Hold |
32,138
| – | – | ﹤0.01% | 1388 |
|
|
2023
Q3 | $1.15M | Buy |
32,138
+8
| +0% | +$285 | ﹤0.01% | 1489 |
|
|
2023
Q2 | $1.48M | Sell |
32,130
-35
| -0.1% | -$1.61K | ﹤0.01% | 1400 |
|
|
2023
Q1 | $1.29M | Buy |
32,165
+19,234
| +149% | +$771K | ﹤0.01% | 1482 |
|
|
2022
Q4 | $599K | Sell |
12,931
-12,929
| -50% | -$599K | ﹤0.01% | 1621 |
|
|
2022
Q3 | $1.07M | Buy |
25,860
+12,934
| +100% | +$535K | ﹤0.01% | 1606 |
|
|
2022
Q2 | $772K | Buy |
12,926
+10
| +0.1% | +$597 | ﹤0.01% | 1486 |
|
|
2022
Q1 | $938K | Sell |
12,916
-23,772
| -65% | -$1.73M | ﹤0.01% | 1551 |
|
|
2021
Q4 | $3.09M | Sell |
36,688
-61,841
| -63% | -$5.2M | ﹤0.01% | 1174 |
|
|
2021
Q3 | $8.89M | Buy |
+98,529
| New | +$8.89M | ﹤0.01% | 935 |
|